AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Attie, KM Bengtsson, BA Blethen, SL Blum, W Cameron, F Carel, JC Carlsson, L Chipman, JJ Christiansen, JS Clayton, P Clemmons, DR Cohen, P Drop, S Fujieda, K Ghigo, E Hintz, RL Ho, K Ilondo, MM Jasper, H Jesussek, B Kappelgaard, AM Laron, Z Lippe, BM Malozowski, S Mullis, PE de Muinck-Keizer-Schrama, S Nishi, Y Parks, JS Phelps, C Ranke, M Robinson, I Rosenfeld, RG Rose, S Saenger, P Saggese, G Savage, M Shalet, S Sizonenko, PC Strasburger, C Tachibana, K Tanaka, T Thorner, MO Wikland, KA Zadik, Z
Citation: Km. Attie et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (Reprinted from J Clin Endocrinol Metab, vol 85, pg 3990-3993,2000), J PED END M, 14(4), 2001, pp. 377-382

Authors: Christiansen, JS Bengtsson, BA Thorner, MO Hintz, R Sonksen, PH Cohen, P Clemmons, D Strasburger, CJ Carlsson, L Tanaka, T Robinson, I Jorgensen, JO Johannson, G Clayton, PE Cowell, CT Malozowski, SN Hankinson, S Yee, D Baxter, R Swerdlow, A Rosenfeld, R Fradkin, JE Nishi, Y Monson, JP van den Berghe, G Carroll, PV Takala, J van der Lely, AJ Pollak, MN LeRoith, D Tachibana, K Kappelgaard, AM Langbakke, I Lippe, B Wilton, P Stein, P Salazar, DE Maneatis, T Blethen, SL Cutler, GB Blum, WF Svanberg, E Gertner, JM Shimatsu, A Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870

Authors: Reiter, EO Blethen, SL Baptista, J Price, L
Citation: Eo. Reiter et al., Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome, J CLIN END, 86(5), 2001, pp. 1936-1941

Authors: Blackett, PR Rundle, AC Frane, J Blethen, SL
Citation: Pr. Blackett et al., Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy, INT J OBES, 24(2), 2000, pp. 232-235

Authors: Israel, E Attie, KM Bengtsson, BA Blethen, SL Blum, W Cameron, F Carel, JC Carlsson, L Chipman, JJ Christiansen, JS Clayton, P Clemmons, DR Cohen, P Drop, S Fujieda, K Ghigo, E Hintz, RL Ho, K Ilondo, MM Jasper, H Jesussek, B Kappelgaard, AM Laron, Z Lippe, BM Malozowski, S Mullis, PE de Munick-Keizer-Schrama, S Nishi, Y Parks, JS Phelps, C Ranke, M Robinson, I Rosenfeld, RG Rose, S Saenger, P Saggese, G Savage, M Shalet, S Sizonenko, PC Strasburger, C Tachibana, K Tanaka, T Thorner, MO Wikland, KA Zadik, Z
Citation: E. Israel et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society, J CLIN END, 85(11), 2000, pp. 3990-3993

Authors: Petryk, A Richton, S Sy, JP Blethen, SL
Citation: A. Petryk et al., The effect of growth hormone treatment on stature in Aarskog syndrome, J PED END M, 12(2), 1999, pp. 161-165

Authors: Ng, LLC Chasalow, FI Escobar, O Blethen, SL
Citation: Llc. Ng et al., Growth hormone isoforms in a girl with gigantism, J PED END M, 12(1), 1999, pp. 99-106

Authors: Kohn, B Julius, JR Blethen, SL
Citation: B. Kohn et al., Combined use of growth hormone and gonadotropin-releasing hormone analogues: The National Cooperative Growth Study experience, PEDIATRICS, 104(4), 1999, pp. 1014-1017

Authors: Bright, GM Julius, JR Lima, J Blethen, SL
Citation: Gm. Bright et al., Growth hormone stimulation test results as predictors of recombinant humangrowth hormone treatment outcomes: Preliminary analysis of the National Cooperative Growth Study database, PEDIATRICS, 104(4), 1999, pp. 1028-1031
Risultati: 1-9 |